2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$5.12+$0.03 (+0.49%)
Price as of Sep 11, 2026 7:30 PM EDT- $307.8MMarket Cap
- 12.86%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$5.12+$0.03 (+0.49%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.09 | ||
Change | +$0.05 (+0.99%) | ||
Open | $5.10 | ||
High | $5.17 | ||
Low | $5.05 | ||
Previous Close | $5.04 | ||
Volume | 701,226 | ||
30-Day Average Volume | 779,209 | ||
1-Week Change | -6.26% | ||
1-Month Change | 3.25% | ||
1-Year Change | 12.86% | ||
3-Year Change | 8.53% | ||
5-Year Change | -68.56% | ||
Fundamentals | |||
Shares Outstanding | 60.5M | ||
Total Assets | $412.5M | ||
Market Cap | $307.8M | ||
Enterprise Value | $251.9M | ||
Period: QTR TTM FY | |||
Revenue | $50.5M | ||
Net Income | -$62.5M | ||
Free Cash Flow | -$31.3M | ||
EBIT | -$62.4M | ||
EBITDA | -$60.4M | ||
Net Working Capital | $100.5M | ||
EPS | -$1.04 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue